Om
Anabolic Steroids: Uses, Side Effects, And Alternatives
An Overview of Anabolic Steroids – Facts, Uses, Risks and Alternatives
---
1. Introduction
Anabolic‑steroid compounds are synthetic derivatives of the male sex hormone testosterone. They possess two main pharmacological actions:
Action Effect
Anabolism (muscle building) Increases protein synthesis in skeletal muscle, leading to hypertrophy.
Androgenic (male‑characteristic traits) Stimulates development of secondary sex characteristics such as facial hair, deepening of the voice, and increased libido.
The dual nature of these hormones explains why they are used both medically (e.g., treating hormone deficiencies, muscle wasting disorders) and illicitly for performance enhancement or body‑building purposes.
---
2. A Detailed Look at Testosterone
Testosterone is the most well‑known endogenous steroid hormone that exerts significant anabolic and androgenic effects in men.
Category Details
Chemical Formula C₃₂H₄₀O₂
Molecular Weight 288.43 g/mol
Structure A cyclopentanoperhydrophenanthrene nucleus with a double bond between C4–C5, an aldehyde at C17α (in the enone form), and a hydroxyl group at C3.
Sources Primarily produced by Leydig cells in testes; small amounts from adrenal cortex.
Metabolism Reduced to testosterone or oxidized to dihydrotestosterone via 5α-reductase.
Half-life (oral) ~2–4 hours (short due to rapid hepatic metabolism).
---
2. Synthesis of the Hormone (Testosterone) – General Route
Below is a concise outline of a common laboratory synthesis for testosterone starting from commercially available precursors.
2.1 Overview of Steps
Step Transformation Key Reagents & Conditions
A Conversion of cholesterol to Δ⁵-sterol (e.g., pregnenolone) Acidic or enzymatic cleavage; e.g., using cholesterol oxidase, followed by oxidation.
B Formation of the Δ⁴-pregnene core (pregnenolone → progesterone) Oxidation with PCC or Swern conditions to introduce a ketone at C-20 and eliminate C-3 hydroxyl.
C Reduction & epoxidation to form the A‑ring double bond (progesterone → 5α‑dihydroprogesterone) Stereoselective reduction with NaBH₄, followed by epoxidation at C-4/5 with mCPBA.
D Opening of the epoxide and installation of C‑3 hydroxyl (via diol cleavage) Acidic hydrolysis to yield a 3‑OH group while maintaining stereochemistry.
E Alkene isomerization & selective oxidation at C‑11 (to form 11‑hydroxy group) Sharpless epoxidation on the alkene, followed by oxidative cleavage with KMnO₄ or OsO₄/H₂O₂ to yield a ketone/aldehyde at C‑11.
F Final reduction & dehydration steps to produce the unsaturated lactone ring (β‑unsaturation) Wittig olefination to introduce double bond, then intramolecular esterification with a base (NaH or LiHMDS) to close lactone ring and form conjugated system.
1.3 Detailed Stepwise Transformation
Below is an annotated, step-by-step transformation plan from the starting material \(S\) to the target compound \(T\). Each entry includes reagents, stoichiometry, reaction conditions, and rationale.
Step Transformation Reagents & Conditions Notes / Rationale
1 Protect phenol as methyl ether NaH (1.5 equiv), THF, rt → 60 °C, 2 h; then MeI (1.5 equiv) Avoids phenolic acidity that could interfere with subsequent deprotonation
2 Deprotect methoxy group (if needed) BBr₃ (1.0 equiv) in DCM, –78 °C → rt, 12 h Regenerates free phenol for further functionalization
3 Synthesize α‑amino ester Standard coupling of amino acid with H₂N‑CH₂CO₂H via carbodiimide chemistry (DCC/HOBt) Forms the core skeleton for the peptide chain
4 Reduce nitro group to amine SnCl₂·2H₂O in ethanol, reflux Converts aromatic nitro to amino, enabling further substitution
5‑7. Peptide coupling steps Use HATU/DIPEA in DMF; N‑terminal protection with Boc or Fmoc; deprotection with TFA (Boc) or piperidine (Fmoc) Assemble the peptide sequence stepwise, controlling stereochemistry
8. Final deprotection & purification Removal of side‑chain protecting groups (e.g., trifluoroacetic acid for tert‑butyl and tBu esters), reverse‑phase HPLC Isolate pure compound; confirm purity >99%
Key Reagents/Conditions:
Step Typical Reagent Conditions
Coupling HATU / DIC / EDCI + DIPEA 0 °C → rt, 1–3 h
Protection Boc anhydride (di-tert-butyl dicarbonate) 0 °C → rt, 2–4 h
Deprotection TFA in DCM (1:9 v/v) 30 min – 1 h
Reductive alkylation NaBH(OAc)₃ + aldehyde 0 °C → rt, 12–18 h
Saponification LiOH or NaOH in MeOH/H₂O rt, 2–4 h
---
5. Summary of the Synthetic Route
Protection – Boc‑protect the primary amine(s) to prevent side reactions.
Linker Assembly – Couple the protected amine with a linker fragment (e.g., ethylene glycol spacer, PEG unit, or triazole from click chemistry).
Target Attachment – Introduce the target ligand by coupling an activated acid/anhydride or via click chemistry to yield the final conjugate.
Deprotection / Finalization – Remove protecting groups and perform any necessary purification (HPLC, chromatography) to obtain the pure functionalized compound.
This general strategy accommodates a wide range of functional groups, ensuring that the final molecule is compatible with downstream biological applications.
Køn: Kvinde
